1,165
Views
19
CrossRef citations to date
0
Altmetric
LAboratory Study

Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran

, , , , , & show all
Pages 970-973 | Received 07 Jan 2016, Accepted 21 Mar 2016, Published online: 20 Apr 2016

References

  • Fishman JA. Opportunistic infections—Coming to the limits of immunosuppression? Cold Spring Harb Perspect Med. 2013;3:a015669.
  • Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601–2614.
  • Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715–2729.
  • Cohen SN. Toxoplasmosis in patients receiving immunosuppressive therapy. JAMA. 1970;211:657–660.
  • Cohen BA, Stosor V. Opportunistic infections of the central nervous system in the transplant patient. Curr Neurol Neurosci Rep. 2013;13:1–12.
  • Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976.
  • Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol. 2012;7:1–17.
  • Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–1101.
  • Castagnini M, Bernazzali S, Ginanneschi C, et al. Fatal disseminated toxoplasmosis in a cardiac transplantation with seropositive match for Toxoplasma: should prophylaxis be extended? Transplant Immunol. 2007;18:193–197.
  • Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Basic science and dialysis: disturbances of acquired immunity in hemodialysis patients. Semin Dialysis. 2007;20:440–451.
  • Alter MJ, Lyerla RL, Tokars JI, Miller ER, Arduino MJ. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR. 2001;50:1–43.
  • Saki J, Khademvatan S, Soltani S, Shahbazian H. Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods. Parasitol Res. 2013;112:163–168.
  • Clissold R, Bingham C. Late presentation of toxoplasmosis in renal transplant recipients. NDT Plus 2010;3:480–482.
  • Vaughan L, Wenzel R. Disseminated toxoplasmosis presenting as septic shock five weeks after renal transplantation. Transpl Infect Dis. 2013;15:E20–E24.
  • Nasser Q, Power R, Eng M, Hickey D, Little D. Toxoplasmosis after a simultaneous pancreas and kidney transplantation. Transplant Proceed. 2004;36(9):2843–2844.
  • Wulf M, Van Crevel R, Portier R, et al. Toxoplasmosis after renal transplantation: Implications of a missed diagnosis. J Clin Microbiol. 2005;43:3544–3547.
  • Renoult E, Georges E, Biava M-F, et al. Toxoplasmosis in kidney transplant recipients: Report of six cases and review. Clin Infect Dis. 1997;24:625–634.
  • Jeong Y-H, Park J-W, Do J-Y, et al. Toxoplasmosis after kidney transplantation. J Korean Soc Transplant. 2013;27:185–189.
  • Segall L, Moal MC, Doucet L, Kergoat N, Bourbigot B. Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transpl Int. 2006;19:78–80.
  • Rogers N, Peh CA, Faull R, Pannell M, Cooper J, Russ G. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transplant Infect Dis. 2008;10:71–74.
  • Daryani A, Sarvi S, Aarabi M, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: A systematic review and meta-analysis. Acta Tropica. 2014;137:185–194.
  • Ahmadpour E, Daryani A, Sharif M, et al. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2014;8:1503–1510.
  • Bayani M, Mostafazadeh A, Oliaee F, Kalantari N. The prevalence of Toxoplasma gondii in hemodialysis patients. Iranian Red Crescent Med J. 2013;15:e5225.
  • Ebrahim Zadeh A, Bamedi T, Etemadi S, Shahrakipour M, Saryazdipour K. Toxoplasmosis as a complication of transfusion in hemodialysis patients. Iran J Ped Hematol Oncol. 2014;4:22–25.
  • Maraghi S, Yadyad MJ, Sheikhi M, Shamakhteh F, Latifi SM. Study the anti-Toxoplasma antibodies (IgG and IgM) in hemodialysis patients of Abadan and Khoramshahr cities southwest Iran in 2011 using ELISA. Jundishapur J Microbiol. 2013;6:e7113. DOI: 10.5812/jjm.7113.
  • Aghighi M, Heidary Rouchi A, Zamyadi M, et al. Dialysis in Iran. Iran J Kidney Dis. 2008;2:11–15.
  • Ghods AJ. Renal transplantation in Iran. Nephrol Dial Transplant. 2002;17:222–228.
  • Mahdavi-Mazdeh M. The Iranian model of living renal transplantation. Kidney Int. 2012;82:627–634.
  • Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol. 2006;1:1136–1145.
  • Fernàndez-Sabé N, Cervera C, Fariñas MC, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: A matched case–control study. Clin Infect Dis. 2011;54:355–361.
  • Khan A, Su C, German M, Storch G, Clifford D, Sibley LD. Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol. 2005;43:5881–5887.
  • Demirtaş F, Yalçin Ş, Yaman O, Tokgöz B, Utaş C, Şahin İ. Anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure. Yonsei Med J. 2003;44:288–292.
  • Robert-Gangneux F, Dardé M-L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264–296.
  • Liu Q, Wang Z-D, Huang S-Y, Zhu X-Q. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015;8:292. DOI: 10.1186/s13071-015-0902-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.